165 related articles for article (PubMed ID: 30420287)
1. Long noncoding RNA LSINCT5 acts as an oncogene via increasing EZH2-induced inhibition of APC expression in osteosarcoma.
Kong D; Li C; Yang Q; Wei B; Wang L; Peng C
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):193-197. PubMed ID: 30420287
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA PCAT-1 acts as an oncogene in osteosarcoma by reducing p21 levels.
Huang J; Deng G; Liu T; Chen W; Zhou Y
Biochem Biophys Res Commun; 2018 Jan; 495(4):2622-2629. PubMed ID: 29291409
[TBL] [Abstract][Full Text] [Related]
3. The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma.
Liu K; Ni JD; Li WZ; Pan BQ; Yang YT; Xia Q; Huang J
Mol Oncol; 2020 Oct; 14(10):2678-2695. PubMed ID: 32634265
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA UFC1 acts as an oncogene via stimulating EZH2-induced inhibition of APC expression in renal cell carcinoma.
Wang J; Liu G
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21.
Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H
Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
Yang G; Song R; Wang L; Wu X
Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
[TBL] [Abstract][Full Text] [Related]
8. LSINCT5 predicts unfavorable prognosis and exerts oncogenic function in osteosarcoma.
He W; Lu M; Xiao D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967495
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA LSINCT5 promotes malignancy in non-small cell lung cancer by stabilizing HMGA2.
Tian Y; Zhang N; Chen S; Ma Y; Liu Y
Cell Cycle; 2018; 17(10):1188-1198. PubMed ID: 29883241
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of the long non‑coding RNA FOXD2‑AS1 inhibits cell proliferation, migration and invasion in osteosarcoma.
Zhang H; Lu Y; Wang J; Zhang T; Dong C; Li X; Wang X; Ma Q; Yang T; Zhou Y
Mol Med Rep; 2019 Jul; 20(1):292-302. PubMed ID: 31115575
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
[TBL] [Abstract][Full Text] [Related]
13. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
14. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
[TBL] [Abstract][Full Text] [Related]
15. LSINCT5 activates Wnt/β-catenin signaling by interacting with NCYM to promote bladder cancer progression.
Zhu X; Li Y; Zhao S; Zhao S
Biochem Biophys Res Commun; 2018 Jul; 502(3):299-306. PubMed ID: 29772237
[TBL] [Abstract][Full Text] [Related]
16. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
17. Decreased long non-coding RNA lincFOXF1 indicates poor progression and promotes cell migration and metastasis in osteosarcoma.
Yang S; Chen J; Lv B; Zhang J; Li D; Huang M; Yuan L; Yin G
J Cell Mol Med; 2020 Nov; 24(21):12633-12641. PubMed ID: 32945076
[TBL] [Abstract][Full Text] [Related]
18. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling.
Li R; Liu S; Li Y; Tang Q; Xie Y; Zhai R
Mol Med Rep; 2018 Aug; 18(2):1616-1622. PubMed ID: 29901121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
